FIELD: pharmaceutical industry; biotechnology.
SUBSTANCE: group of inventions relates to a prolonged release drug delivery agent, characterized by that it is a water-soluble or colloidal particle with size of 100–600 nm, which has 3D matrix structure formed from complexes of a derivative β-cyclodextrin, containing at least three free hydroxyl groups, and a drug compound containing at least one aromatic moiety, where derivatives β-cyclodextrin are interconnected by urethane bonds; as well as to a method for preparing said agent.
EFFECT: implementing the group provides a prolonged action of the drug included in the particles.
11 cl, 6 dwg, 2 tbl, 14 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PURIFIED DERIVATIVES OF SULFOALKYL ETHERS OF CYCLODEXTRINE OR THEIR MIXTURE, CLATRATE COMPLEX OF CYCLODEXTRINE DERIVATIVES WITH MEDICINAL, AND PHARMACEUTICAL COMPOSITION | 1993 |
|
RU2113442C1 |
| METHOD OF NON-INJECTION ADMINISTRATION OF THERAPEUTIC AND PROPHYLACTIC DRUGS FOR FISH FARMING | 2023 |
|
RU2810583C1 |
| LIPOSOME HAVING INNER AQUEOUS PHASE AND CONTAINING SULPHOBUTYL ESTER CYCLODEXTRIN SALT | 2010 |
|
RU2575793C2 |
| PURIFIED DERIVATIVE OF CYCLODEXTRINE, CLATHRATE COMPLEX OF PURIFIED DERIVATIVE OF CYCLODEXTRINE WITH DRUG, PHARMACEUTICAL COMPOSITION | 1992 |
|
RU2099354C1 |
| METHODS OF TREATMENT OF EPILEPSY OR STATUS EPILEPTICUS | 2013 |
|
RU2667010C2 |
| METHODS OF TREATMENT OF EPILEPSY OR STATUS EPILEPTICUS | 2013 |
|
RU2824132C2 |
| INCLUSION COMPLEXES-CONTAINING COMPOSITIONS | 2001 |
|
RU2288921C2 |
| METHOD FOR OBTAINING SUSPENSION CONTAINING NANOSIZED PARTICLES OF DRUG | 2020 |
|
RU2756757C1 |
| NEUROACTIVE STEROID FORMULATIONS AND METHODS OF TREATING CNS DISORDERS | 2013 |
|
RU2681835C2 |
| SOLID PHARMACEUTICAL PREPARATIONS CONTAINING PHYSICAL MIXTURE OF CYCLODEXTRIN SULFOALKYL ETHER AND THERAPEUTIC AGENT | 1998 |
|
RU2173172C2 |
